Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Cryo-Cell International Inc
CCEL | US
3.56
USD0.12
3.49%
CCEL | US
About Cryo-Cell International Inc
Sector
Healthcare
Industry
Medical Care Facilities
Earnings date
31/08/2024
As of date
20/04/2026
Close
3.56
Open
3.59
High
3.60
Low
3.41
Cryo-Cell International Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions including heart and kidney disease ALS wound healing and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents as well as by distributing information through obstetricians pediatricians childbirth educators certified nurse-midwives and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar Florida.
View LessCCEL | US
Risk
69.5
Sharpe
-0.86
Luna's Score
45/100
Recommendation
Sell
Luna says (CCEL | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
What's not Working
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
77.1%1 month
69.5%3 months
46.1%6 months
49.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
9.72
Debt to equity
-0.34
Debt to assets
0.05
Ent. to EBITDA
-6.69
Ent. to rev.
1.91
PEG
-
Other Fundamentals
EBITDA
641.30K
MarketCap
28.70M
MarketCap(USD)
28.70M
Div. yield
-
Op. margin
17.39
Erngs. growth
62.50
Rev. growth
2.50
Ret. on equity
129.20
Short ratio
2.91
Short perc.
0.23
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.66
Range1M
1.29
Range3M
1.29
Volumes: Market Activity
Rel. volume
0.75
Price X volume
35.76K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -6.69 | - | Cheaper |
| Ent. to Revenue | 1.91 | - | Par |
| PE Ratio | - | 22.94 | - |
| Price to Book | 9.72 | 14.91 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 46.07 | - | Par |
| Debt to Equity | -0.34 | 5.15 | Cheaper |
| Debt to Assets | 0.05 | 0.46 | Cheaper |
| Market Cap | 28.70M | - | Emerging |
